| Crystal structure of human LTA4H mutant E271A in complex with LTA4 (crystal form II) | | homo-3-mer | 3-610 | 99.83 | 3×ZN; 7×IMD; 3×DJ3; |
|
| [E296Q]LTA4H in complex with RSR substrate | | monomer | 2-611 | 99.84 | 1×ZN; 1×YB; 1×ACY; 1×GOL; |
|
| Crystal structure of leukotriene a4 hydrolase in complex with 2-amino-N-[4-(phenylmethoxy)phenyl]-a… | | monomer | 2-611 | 100 | 1×ZN; 1×YB; 1×ACT; 1×4BG; |
|
| Complex of human leukotriene A4 hydrolase with a hydroxamic acid inhibitor | | monomer | 2-611 | 100 | 1×ZN; 3×YB; 1×IMD; 1×ACT; 1×HA2; |
|
| Leukotriene A4 Hydrolase Complexed with Inhibitor RB3040 | | monomer | 2-611 | 100 | 1×ZN; 1×YB; 1×IMD; 1×BIR; |
|
| Leukotriene A4 hydrolase complexed with inhibitor RB3041 | | monomer | 2-611 | 100 | 1×ZN; 1×YB; 1×PH0; 1×ACY; |
|
| Leukotriene A4 Hydrolase Complexed with KELatorphan | | monomer | 2-611 | 100 | 1×ZN; 3×YB; 1×IMD; 1×KEL; 1×ACY; |
|
| STRUCTURE OF LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH BESTATIN. | | monomer | 2-611 | 100 | 1×ZN; 3×YB; 1×ACT; 1×BES; 1×IMD; |
|
| STRUCTURE OF [E271Q]LEUKOTRIENE A4 HYDROLASE | | monomer | 2-611 | 99.84 | 1×ZN; 1×YB; 1×ACY; 1×IMD; |
|
| Crystal structure of leukotriene A4 hydrolase in complex with 4-amino-N-[4-(phenylmethoxy)phenyl]-b… | | monomer | 2-611 | 100 | 1×ZN; 1×YB; 1×4BS; 1×IMD; |
|
| STRUCTURE OF LEUKOTRIENE A4 HYDROLASE D375N MUTANT | | monomer | 2-611 | 99.84 | 1×BES; 1×ACT; 1×IMD; 1×YB; 1×ZN; |
|
| STRUCTURE OF [R563A] LEUKOTRIENE A4 HYDROLASE | | monomer | 2-611 | 99.84 | 1×ZN; 1×YB; 1×IMD; 1×ACY; |
|
| [E296Q]LTA4H in complex with Arg-Ala-Arg substrate | | monomer | 2-611 | 99.84 | 1×ZN; 2×YB; 1×IMD; |
|
| Crystal structure of leukotriene A4 hydrolase in complex with (2S)-2-amino-5-[[4-[(2S)-2-hydroxy-2-… | | monomer | 2-611 | 100 | 1×ZN; 3×YB; 1×IMD; 1×4BU; |
|
| Crystal structure of human LTA4H mutant D375N in open conformation (crystal form II) | | monomer | 2-610 | 99.84 | 1×ZN; |
|
| Crystal structure of human LTA4H mutant D375N in open conformation (crystal form I) | | monomer | 2-610 | 99.84 | 1×ZN; |
|
| Structure of human Leukotriene A4 hydrolase in complex with inhibitor sc57461A | | monomer | 4-611 | 100 | 1×ZN; 8×YB; 2×CL; 3×IMD; 1×GOL; 1×28P; 1×ACT; |
|
| Crystal structure of human LTA4H mutant D375N in complex with LTA4 | | monomer | 4-611 | 99.84 | 1×ZN; 2×YB; 2×ACY; 1×DJ3; |
|
| Human Leukotriene A4 Hydrolase in complex with Pro-Gly-Pro analogue and 4-(4-benzylphenyl)thiazol-2… | | monomer | 4-611 | 100 | 1×ZN; 1×28T; 1×1V6; 2×YB; 2×ACY; |
|
| Human Leukotriene A4 Hydrolase in complex with Pro-Gly-Pro analogue | | monomer | 4-611 | 100 | 1×ZN; 1×28T; 5×YB; 2×ACY; |
|
| Structure of human Leukotriene A4 hydrolase in complex with inhibitor dimethyl(2- (4-phenoxyphenoxy… | | monomer | 4-611 | 100 | 1×DP8; 1×ZN; 4×YB; 2×IMD; |
|
| Leukotriene A4 hydrolase in complex with 1-[2-(1H-indol-5-yloxy)ethyl]piperidine-4-carboxylic acid | | monomer | 4-611 | 100 | 1×ZN; 1×YB; 1×58Z; 1×ACT; 2×IMD; |
|
| LTA4 hydrolase in complex with Compound11 | | monomer | 4-611 | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×BGW; |
|
| Crystal structure of leukotriene a4 hydrolase in complex with (3S)-3-amino-4-oxo-4-[(4-phenylmethox… | | monomer | 4-611 | 100 | 1×ZN; 1×YB; 1×ACT; 1×IMD; 1×4BO; |
|
| Substrate-dependent divergence of leukotriene A4 hydrolase aminopeptidase activity | | monomer | 4-611 | 100 | 1×ZN; 1×N0Y; 1×28T; |
|
| Substrate-dependent divergence of leukotriene A4 hydrolase aminopeptidase activity | | monomer | 4-611 | 100 | 1×ZN; 1×N0Y; |
|
| Leukotriene A4 hydrolase in complex with 4-(4-benzylphenyl)-oxazol-2-amine | | monomer | 5-611 | 100 | 1×ZN; 4×YB; 4×ACT; 2×IMD; 1×OVO; 2×GOL; |
|
| Leukotriene A4 hydrolase in complex with 4-(4-Benzylphenyl)-selenazol-2-amine | | monomer | 5-611 | 100 | 1×ZN; 3×YB; 4×ACT; 2×IMD; 1×OD6; 2×GOL; |
|
| Crystal structure of human LTA4H mutant E271A in complex with LTA4 (crystal form I) | | monomer | 4-610 | 99.83 | 1×ZN; 2×YB; 1×DJ3; |
|
| LTA4 hydrolase in complex with compound 6(R) | | monomer | 5-611 | 100 | 1×ZN; 1×ACT; 3×YB; 2×IMD; 1×WEE; |
|
| Human Leukotriene A4 Hydrolase complexed with ligand 4-(4-benzylphenyl)thiazol-2-amine | | monomer | 5-611 | 100 | 1×ZN; 1×1V6; 4×YB; 3×ACT; |
|
| Structure of Human Leukotriene A4 Hydrolase in complex with inhibitor H1 | | monomer | 4-610 | 100 | 1×ZN; 1×YB; 3×GOL; 2×ACT; 1×IMD; 1×SHH; |
|
| Leukotriene A4 Hydrolase complexed with inhibitor 1-[2-(4-benzylphenoxy)ethyl]pyrrolidine. | | monomer | 5-611 | 100 | 1×ZN; 3×YB; 1×ACT; 1×IMD; 1×27P; |
|
| Leukotriene A4 hydrolase in complex with fragment N-(pyridin-3-ylmethyl)aniline | | monomer | 5-611 | 100 | 1×ZN; 2×YB; 1×11X; 1×IMD; |
|
| LTA4 hydrolase in complex with fragment2 | | monomer | 5-611 | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×RZK; |
|
| Leukotriene A4 hydrolase in complex with fragment 4-(4-fluorobenzoyl)pyridine | | monomer | 5-611 | 100 | 1×ZN; 2×YB; 1×22F; 1×ACT; 1×IMD; |
|
| Leukotriene A4 hydrolase in complex with fragment 5-hydroxyindole and bestatin | | monomer | 5-611 | 100 | 1×ZN; 3×YB; 1×5H1; 1×BES; 1×IMD; |
|
| LTA4 hydrolase (E297Q) mutant in complex with Pro-Gly-Pro peptide | | monomer | 5-611 | 99.83 | 1×ZN; 1×ACT; 2×YB; 1×IMD; |
|
| Leukotriene A4 hydrolase in complex with fragments N-(pyridin-3-ylmethyl)aniline and acetate | | monomer | 5-611 | 100 | 1×ZN; 1×YB; 1×11X; 2×ACT; 2×IMD; |
|
| LTA4 hydrolase in complex with compound2 | | monomer | 5-611 | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×A1H3S; |
|
| LTA4 hydrolase in complex with CTX-4430 | | monomer | 5-611 | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×A1H3T; |
|
| LTA4 hydrolase in complex with compound R(13) | | monomer | 5-611 | 100 | 1×ZN; 1×ACT; 3×YB; 2×IMD; 1×RZB; |
|
| LTA4 hydrolase in complex with compound LYS006 | | monomer | 5-611 | 100 | 1×ZN; 1×ACT; 3×YB; 2×IMD; 1×RZE; |
|
| Crystal structures of the Human leukotriene A4 Hydrolase complex with a potential inhibitor H7 | | monomer | 5-611 | 100 | 1×B3N; 1×ZN; 1×YB; 1×ACY; 1×IMD; |
|
| Crystal Structure Analysis of the Human Leukotriene A4 Hydrolase | | monomer | 5-611 | 100 | 1×YB; 1×ZN; 2×ACT; 3×IMD; 2×GOL; 2×ACY; |
|
| LTA4 hydrolase in complex with fragment1 | | monomer | 5-611 | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×RZN; |
|
| Leukotriene A4 hydrolase in complex with dihydroresveratrol and bestatin | | monomer | 5-611 | 100 | 1×ZN; 3×YB; 1×RE2; 1×BES; 1×ACT; 1×IMD; |
|
| LTA4 hydrolase in complex with compound 6(S) | | monomer | 5-611 | 100 | 1×ZN; 1×ACT; 3×YB; 2×IMD; 1×WSL; |
|
| Structure of human Leukotriene A4 hydrolase in complex with inhibitor captopril | | monomer | 5-611 | 100 | 1×ZN; 1×X8Z; 5×YB; 1×ACY; 2×GOL; |
|
| Structure of human Leukotriene A4 hydrolase in complex with inhibitor 4AZ | | monomer | 5-611 | 100 | 1×ZN; 3×YB; 1×ACT; 1×A4Z; |
|
| Apo structure of human Leukotriene A4 hydrolase | | monomer | 5-611 | 100 | 1×ACT; 1×ZN; 6×YB; 3×IMD; |
|
| Leukotriene A4 Hydrolase complexed with inhibitor 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}pyr… | | monomer | 5-611 | 100 | 1×ZN; 3×YB; 1×ACT; 1×IMD; 1×25P; 1×GOL; |
|
| Crystal structure of leukotriene a4 hydrolase in complex with N5-[4-(phenylmethoxy)phenyl]-L-glutam… | | monomer | 4-610 | 100 | 1×ZN; 3×YB; 1×IMD; 1×4BQ; |
|
| Leukotriene A4 Hydrolase complexed with inhibitor N-[3-(4-benzylphenoxy)propyl]-N-methyl-beta-alani… | | monomer | 5-611 | 100 | 1×ZN; 3×YB; 1×ACT; 1×IMD; 1×28P; |
|
| LTA4 hydrolase in complex with Compound15 | | monomer | 5-611 | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×BGK; |
|
| Leukotriene A4 hydrolase in complex with resveratrol | | monomer | 5-611 | 100 | 1×ZN; 1×YB; 1×STL; 1×ACT; 1×IMD; |
|
| LTA4 hydrolase in complex with compound 2(S) | | monomer | 5-611 | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×WID; |
|
| Leukotriene A4 hydrolase in complex with fragment 5-chloroindole and bestatin | | monomer | 5-611 | 100 | 1×ZN; 3×YB; 1×11S; 1×BES; 1×IMD; |
|
| Leukotriene A4 hydrolase in complex with fragment 5-fluoroindole and bestatin | | monomer | 5-611 | 100 | 1×ZN; 3×YB; 1×14O; 1×BES; 1×IMD; |
|
| The effect of modifier structure on the activation of leukotriene A4 hydrolase aminopeptidase activ… | | monomer | 5-611 | 100 | 1×LNJ; 1×ZN; |
|
| LTA4 hydrolase in complex with compound3 | | monomer | 5-611 | 100 | 1×ZN; 1×ACT; 3×YB; 2×IMD; 1×A1H3U; |
|
| Leukotriene A4 hydrolase in complex with {4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphe… | | monomer | 5-610 | 100 | 1×ZN; 1×YB; 1×798; 1×ACT; 2×IMD; |
|
| Leukotriene A4 Hydrolase complexed with inhibitor (2R)-2-[(4-benzylphenoxy)methyl]pyrrolidine. | | monomer | 5-610 | 100 | 1×ZN; 2×YB; 1×ACT; 2×IMD; 1×24P; 1×GOL; |
|
| Leukotriene A4 hydrolase in complex with dihydroresveratrol | | monomer | 5-610 | 100 | 1×ZN; 1×YB; 1×RE2; 1×ACT; 1×IMD; |
|
| Leukotriene A4 hydrolase in complex with 5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole | | monomer | 5-610 | 100 | 1×ZN; 1×YB; 1×00G; 1×ACT; 2×IMD; |
|
| Leukotriene A4 hydrolase in complex with fragment 2-(pyridin-3-ylmethoxy)aniline | | monomer | 5-610 | 100 | 1×ZN; 1×YB; 1×848; 3×ACT; 2×IMD; |
|
| Leukotriene A4 hydrolase in complex with fragment 4-(2-amino-1,3-thiazol-4-yl)phenol | | monomer | 5-610 | 100 | 1×ZN; 1×YB; 2×92G; 2×ACT; 2×IMD; |
|
| Leukotriene A4 hydrolase in complex with fragment (4-thiophen-2-ylphenyl)methanamine | | monomer | 5-610 | 100 | 1×ZN; 1×YB; 1×80G; 2×ACT; 2×IMD; |
|
| Leukotriene A4 hydrolase in complex with fragment 3-(benzyloxy)pyridin-2-amine | | monomer | 5-610 | 100 | 1×ZN; 1×YB; 1×3IP; 3×ACT; 2×IMD; |
|
| Leukotriene A4 hydrolase in complex with N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline | | monomer | 6-611 | 100 | 3×YB; 1×ZN; 1×812; 1×IMD; |
|
| Leukotriene A4 hydrolase in complex with N-methyl-1-(2-thiophen-2-ylphenyl)methanamine | | monomer | 5-610 | 100 | 1×ZN; 1×YB; 1×692; 1×ACT; 2×IMD; |
|
| Crystal structure of LTA4H bound to a selective inhibitor against LTB4 generation | | monomer | 5-610 | 100 | 1×ZN; 1×YB; 1×IMD; 1×8KW; 1×ACT; |
|
| Leukotriene A4 hydrolase in complex with (5-thiophen-2-ylthiophen-2-yl)methylamine | | monomer | 5-610 | 100 | 1×ZN; 1×YB; 1×492; 1×ACT; 2×IMD; |
|
| Crystal structure of human LTA4H mutant R563A in open conformation | | monomer | 5-610 | 99.83 | 1×ZN; |
|
| Synthesis and Evaluation of Diaryl Ether Modulators of the Leukotriene A4 Hydrolase Aminopeptidase … | | monomer | 5-610 | 100 | 1×VI7; 1×ZN; |
|
| Leukotriene A4 hydrolase in complex with (R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol | | monomer | 6-610 | 100 | 1×ZN; 1×YB; 1×80A; 1×ACT; 2×IMD; |
|
| Leukotriene A4 hydrolase in complex with pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanone | | monomer | 6-610 | 100 | 1×ZN; 1×YB; 1×52D; 2×IMD; |
|